FOX News unintentionally broke the story about how Monsanto is poisoning our milk and dairy products. Monsanto sells 'posilac' to farmers > farmers inject posilac into milk producing cows under the premise that the cows will produce more milk > the cows get sick and develop acne-like sores (including mastitis on their udders) > the farmers inject antibiotics to keep the sick cows from dying.

Meanwhile, children in American Schools are drinking milk from sick cows that STILL contains Monsanto's Posilac, the antibiotics, and pus that drips from open sores on their infected udders into the milk buckets.

Monsanto was granted regulatory approval for its FIRST BIOTECH product, a dairy cow hormone. Monsanto developed a recombinant version of BST, brand-named Posilac bovine somatropin (rBST/rBGH), which is produced through a genetically engineered GMO E. coli bacteria. Synthetic Bovine Growth Hormone (rBGH), approved by the FDA for commercial sale in 1994, despite strong concerns about its safety. Since then, Monsanto has sued small dairy companies that advertised their products as free of the artificial hormone, including Ben & Jerry's ice cream and most recently bringing a lawsuit against Oakhurst Dairy in Maine.

Bovine somatotropin (abbreviated bST and BST), also known as bovine growth hormone, or BGH, is a protein hormone. BST is naturally occurring in cattle, and plays a role in the growth and development of the organism. Since 1994 it has been possible to synthesize the hormone using recombinant DNA technology to create recombinant bovine somatotropin (rBST), recombinant bovine growth hormone (rBGH), or artificial growth hormone. Monsanto was the first to develop the technology and marketed it as "Posilac" - a brand now owned by Elanco Animal Health, a division of Eli Lilly and Company (your 'friends' selling polio vaccines).

FOX News unintentionally broke the story about how Monsanto is poisoning our milk and dairy products. Monsanto sells 'posilac' to farmers > farmers inject posilac into milk producing cows under the premise that the cows will produce more milk > the cows get sick and develop acne-like sores (including mastitis on their udders) > the farmers inject antibiotics to keep the sick cows from dying.

Meanwhile, children in American Schools are drinking milk from sick cows that STILL contains Monsanto's Posilac, the antibiotics, and pus that drips from open sores on their infected udders into the milk buckets.

Monsanto was granted regulatory approval for its FIRST BIOTECH product, a dairy cow hormone. Monsanto developed a recombinant version of BST, brand-named Posilac bovine somatropin (rBST/rBGH), which is produced through a genetically engineered GMO E. coli bacteria. Synthetic Bovine Growth Hormone (rBGH), approved by the FDA for commercial sale in 1994, despite strong concerns about its safety. Since then, Monsanto has sued small dairy companies that advertised their products as free of the artificial hormone, including Ben & Jerry's ice cream and most recently bringing a lawsuit against Oakhurst Dairy in Maine.

Michael Taylor once worked for the FDA, later represented Monsanto as a lawyer, then returned as the FDA's Deputy Commissioner for Policy when rBGH was granted approval.

In the wake of mass consumer pressure, major retailers such as Safeway, Publix, Wal-Mart, and Kroger banned store brand milk products containing Monsanto's controversial genetically engineered hormone rBGH. Starbucks, under pressure from the OCA and our allies, has likewise banned rBGH milk.

A recent court ruling found that there **ARE** THREE (3) differences between ORGANIC and rbST/rBGH Monsanto pus milk:

1. HORMONES in the milk can cause CANCER
2. Up to 20% PUS content (white blood cells)
3. DEPLETED NUTRITIONAL VALUE !!!

In October 2010, a U.S. court of appeal found based on studies presented that there IS a "compositional difference" between milk from rBSG-treated cows and untreated milk. The court found that studies have shown that rBST milk has: increased levels of the cancer-causing hormone IGF-1; lower nutritional quality when produced at certain points in the cow's lactation cycle; and more pus in the milk (increased somatic cell counts), which "make the milk turn sour more quickly and is another indicator of poor milk quality."

Two meta-analyses have been published on rBST's effects on bovine health. Findings indicated an average increase in milk output ranging from 11%-16%, a nearly 25% increase in the risk of clinical mastitis, a 40% reduction in fertility and 55% increased risk of developing clinical signs of lameness. The same study reported a decrease in body condition score for cows treated with rBST even though there was an increase in their dry matter intake.

In 1997, very brave and honorable journalists from Florida sued Fox news for asking them to lie and distort the truth about the polluted milk in order to protect THEIR CLIENT Monsanto's RoundUp advertising budget. Steve Wilson and Jane Akre were terminated by television station WTVT. They filed suit, claiming the termination was due to their involvement in an investigative report criticizing Monsanto's use of rBGH, which FOX did NOT air. Wilson and Akre claimed the station had engaged "news distortion" under pressure from Monsanto. WTVT later aired a similar report, which included responses from Monsanto. WTVT ultimately won the suit, and the plaintiff's claims were dismissed. The supreme court of Florida denied Jane Akre's whistle-blower status and ruled that it is NOT illegal for Fox News to lie on their evening news programs.

Use of the recombinant supplement has been controversial. While it is used in the United States (though not without reaction), it is 100% banned in Canada, the European Union (EU), Australia and New Zealand. In Canada, bulk milk products from the United States that have been produced with rBST are still allowed to be sold and used in food manufacture (cheese, yogurt, etc.).

Now that you know WHY there are two different types of milk with the same % of fat - BOYCOTT the milk with the pus in it! Monsanto is trying to get the WARNING LABELS removed from the packaging; people who DRINK MILK want the "NO rBGH" logos to stay.

Several milk purchasers and resellers have elected not to purchase milk produced with rBST.

The nation's largest dairy processor, Dean Foods, no longer sells milk from rBST-treated cows though an email from Dean Foods received by a consumer on September 23, 2010, states, "At Dean Foods, we believe that our dairy producers have the right to produce safe, high-quality milk using any approved and available technology..." which would include Artificial Growth Hormones or rBST/rBGH.

The top 3 grocery retailers in the nation, Wal-Mart, Kroger, and Costco have pledged not to sell such milk in their stores. Specific examples include:

• Winder Farms, a home delivery dairy and grocer in Utah and Nevada, sells rBST-free milk.
• Safeway in the northwestern United States stopped buying from dairy farmers that use rBST in January 2007. The two Safeway plants produce milk for all of Oregon, Southwest Washington, and parts of northern California. Safeway's plant in San Leandro, CA had already been rBST-free for two years.
• Chipotle Mexican Grill has also announced it will serve rBST-free sour cream at its restaurants.
• Kroger has banned rBST-derived milk from all its stores (including its subsidiaries such as Ralphs) as of February 2008,
• Publix announced it has been rBST-free since May, 2007.
• Braum's has also issued a press release stating its milk is rBST-free.
• Starbucks Company has as of January 2008 made all dairy in beverages rBST free.
• Ben & Jerry's ice cream uses milk and cream from dairy farms that have pledged not to use rBST.
• Wal-Mart and Sam's Club stores featured hormone-free "Great Value" brand milk, but did not label it as such in 2008.

Bovine somatotropin (abbreviated bST and BST), also known as bovine growth hormone, or BGH, is a protein hormone. BST is naturally occurring in cattle, and plays a role in the growth and development of the organism. Since 1994 it has been possible to synthesize the hormone using recombinant DNA technology to create recombinant bovine somatotropin (rBST), recombinant bovine growth hormone (rBGH), or artificial growth hormone. Monsanto was the first to develop the technology and marketed it as "Posilac" - a brand now owned by Elanco Animal Health, a division of Eli Lilly and Company (your 'friends' selling polio vaccines).

Monsanto sells U.S. Posilac (rBGH) division to Eli Lilly

In August 2008, Monsanto sold their Posilac division to Eli Lilly and Company for $300 million (who exclusively sold Posilac outside the US for 10 years before the acquisition).

Posilac

In 1937, the administration of BST was "shown" to increase the milk yield in lactating cows by preventing mammary cell death in dairy cattle. Until the 1980s, there was very limited use of the compound in agriculture as the sole source of the hormone was from bovine cadavers. During this time, the knowledge of the structure and function of the hormone increased. Monsanto developed a recombinant version of BST, brand-named Posilac, in 1994, which is produced through a genetically engineered E. coli. A gene that codes for the sequence of amino acids that make up BST is inserted into the DNA of the E. coli bacterium. The bacteria are then broken up and separated from the rBST, which is purified to produce the injectable hormone. Growth hormones associated with injections given to dairy cows to increase milk production are known under an assortment of terms, but these terms, in general, refer to the Monsanto product. The Monsanto fact sheet on its proprietary product states that, "when injected into dairy cattle, the product can increase milk production by an average of more than 10% over the span of 300 days."

Use of Posilac

A 2007 USDA Dairy Survey estimated rBGH use at 15.2% of operations and 17.2% of cows.

An average dairy cow begins her lactation with a moderate daily level of milk production. This daily output increases until, at about 70 days into the lactation, production peaks. From that time until the cow is dry, production slowly decreases. This increase and decrease in production is partially caused by the count of milk-producing cells in the udder. Cell counts begin at a moderate number, increase during the first part of the lactation, then decrease as the lactation proceeds. Once lost, these cells generally do not regrow until the next lactation.

To apply Posilac for maximum effect, farmers are recommended to make the first Posilac application about 50 days into the cow's lactation, just before she peaks. The Posilac then sustains already-present mammary cells, limiting the rate of production decrease after production peaks. After the peak, production declines with or without application of Posilac, but declines more slowly with Posilac than without. This decrease in the rate of production decline permits dairy cows to produce more milk over the span of a lactation - at its best, this will be seen by seven to eight more pounds of milk being produced per day than would be produced without Posilac.

Animal Health Effects

Two meta-analyses have been published on rBST's effects on bovine health. Findings indicated an average increase in milk output ranging from 11%-16%, a nearly 25% increase in the risk of clinical mastitis, a 40% reduction in fertility and 55% increased risk of developing clinical signs of lameness. The same study reported a decrease in body condition score for cows treated with rBST even though there was an increase in their dry matter intake.

A European Union scientific commission was asked to report on the incidence of mastitis and other disorders in dairy cows and on other aspects of the welfare of dairy cows. The commission's statement, subsequently adopted by the European Union, stated that the use of rBST substantially increased health problems with cows, including foot problems, mastitis and injection site reactions, impinged on the welfare of the animals and caused reproductive disorders. The report concluded that, on the basis of the health and welfare of the animals, rBST should NOT be used. Health Canada prohibited the sale of rBST in 1999; the external committees found that, although there was no significant health risk to humans, the drug presents a threat to animal health, and, for this reason, cannot be sold in Canada.

Human Health Effects

Human health concerns center around three areas:

• rBST and its byproducts
• increased levels of IGF
• secondary effects, e.g. the increased use of antibiotics to treat mastitis

IGF is produced by the cow in response to BGH injections, and it is this hormone which increases growth and milk production. Bovine and porcine IGF-I are identical to human IGF-I, while IGF-II differs among animal species.

IGF plays a role in the formation of new tumors and increased levels of IGF-1 may be linked to increased risk of breast, colon, and prostate cancer. However IGF is involved in many biological processes so it is not possible to assign a clear-cut cause and effect relationship. IGF-1 is not denatured by pasteurization, so consumption of milk from rBST treated dairy cows will increase the daily intake of IGF-I.

Further association of IGF with breast cancer was provided by a 20-year epidemiological study begun in 1976, which was published in 1997.

Since 1993 it has been possible to synthesize the hormone using recombinant DNA technology to create recombinant bovine somatotropin (rBST), recombinant bovine growth hormone (rBGH), or artificial growth hormone. Monsanto was the first to develop the technology and marketed it as "Posilac" - a brand now owned by Elanco Animal Health, a division of Eli Lilly and Company (manufacturer of vaccines such as the polio vaccine).

1993: Posilac was approved for use in the U.S. by the FDA, and its use began in 1994. Posilac is now sold in all 50 states.

1994: The first of Monsanto's biotech products to make it to market was not a GM crop but Monsanto's controversial GM cattle drug, bovine growth hormone - called rBGH or rBST, Monsanto granted regulatory approval for its first biotech product, a dairy cow hormone. Monsanto developed a recombinant version of BST, brand-named Posilac bovine somatropin (rBST/rBGH), which is produced through a genetically engineered GMO E. coli bacteria.

Synthetic Bovine Growth Hormone (rBGH) was approved by the FDA for commercial sale in 1994, despite strong concerns about its safety. Since then, Monsanto has sued small dairy companies that advertised non-Monsanto products as free of the artificial hormone, including Ben & Jerry's ice cream and most recently bringing a lawsuit against Oakhurst Dairy in Maine.

1997: The Codex Alimentarius Commission (CAC) considered rBST twice, in 1997 and 1999. Both times, it concluded there was NO consensus rBST was safe for human health. It has not been brought up since.

1998: The JECFA report on rBGH was then submitted to the Codex Committee on Residues of Veterinary Drugs in Foods, chaired by FDA's Director for Veterinary Medicine Dr. Stephen Sundloff who also played a prominent role in the 1998 JECFA Committee. The Codex Committee promptly rubber stamped JECFA's seal of approval for rBGH with the confident expectation that this would be subsequently endorsed by the parent Codex Commission. However, the best laid plans of Monsanto and the FDA were aborted by an unexpected turn of events.

1999: In June, the Codex Alimentarius Commission (CAC) met in Rome; one of its tasks was to set an international standard (a Maximum Residue Limit) for rbST. If established, this standard would imply scientific consensus on the effects of rbST on human health. Since the various delegations were unable to reach agreement, the Commission decided to postpone setting this standard until a consensus could be reached.

2000: The United States is the ONLY developed nation to permit humans to drink milk from cows given artificial growth hormone. Posilac was banned from use in Canada, Australia, New Zealand, Japan and most of Europe, by 2000 or earlier. In the United States, public opinion has caused a number of products and retailers to become rBST-free. The EPA, the National Institute of Health and multiple scientific studies have concluded milk from rBST-treated cows is safe for human consumption.

2007: USDA Dairy Survey estimated rBGH use at 15.2% of operations and 17.2% of cows.

2008: Monsanto sells Posilac business to Eli Lilly (polio vaccine manufacturer) amid consumer and food industry concerns about the dairy cow hormone supplement.

2010: Demand for milk without using synthetic hormones has increased 500% in the US since Monsanto introduced their rBST product. Monsanto has responded to this trend by lobbying state governments to ban the practice of distinguishing between milk from farms pledged not to use rBST and those that do.

2010: In October, a U.S. court of appeal found based on studies presented that there IS a "compositional difference" between milk from rBSG-treated cows and untreated milk. The court found that studies have shown that rBST milk has: increased levels of the cancer-causing hormone IGF-1; lower nutritional quality when produced at certain points in the cow's lactation cycle; and more pus in the milk (increased somatic cell counts), which "make the milk turn sour more quickly and is another indicator of poor milk quality."

No fat can stand the temperatures used in food processing without being adversely affected. (Oleo) Margarine isn't food. It is a manufactured grease concocted in a machine from various oils and chemicals. Then it is colored and molded to pose as butter. Its stiffness comes from being loaded with trans–fatty acids. One concoction has it combined with corn oil. "I can't believe it isn't butter !!"

GMO Canola and GMO Soy fats (oils) are in nearly all margarines. This butter substitute does not exist in nature. It cannot be grown or converted from a natural food as butter and cheese is.

Margarine was invented to win a prize when Napolean III was surrounded and ran a contest for a palatable grease for his otherwise dry bread. Research the word in Britannica. Most restaurants substitute margarine for butter without notice to you. Commercially manufactured ingestibles use margarine wherever butter would be used in their recipe. There are licensed dieticians and physicians who, in total ignorance, will sincerely urge you to eat this poison in pursuit of better health. The usual canard is, "It will reduce your cholesterol levels," a non–sequiter which is yet another awesome fraud. Your brain is mostly cholesterol. And "higher" than average levels are the result of, not the cause of underlying problems.

Margarine: food product made principally from one or more vegetable or animal fats or oils in which is dispersed an aqueous portion containing milk products, either solid or fluid, salt, and such other ingredients as flavouring agents, yellow food pigments, emulsifiers, preservatives, vitamins A and D, and butter. It is used in cooking and as a spread. Nutritionally, margarine is primarily a source of calories.

French chemist H. Mège-Mouriès 1873

The French chemist H. Mège-Mouriès developed margarine in the late 1860s and was given recognition in Europe and a patent in the United States in 1873. His manufacturing method was simplified in the United States into a process in which the melted fat blend was churned with milk and salt, chilled to solidify the mixture, kneaded to a plastic consistency, and packaged, all by means of the standard butter-working equipment of the time. The edible fats used have varied widely, the trend having been from the animal fats predominant in early use to the vegetable fats, principally cottonseed, soybean, coconut, peanut, and corn oils, and, more recently, palm oil. During the late 1950s an increased interest in the relation of polyunsaturated fats and oils to health hastened the shift to corn, safflower, and sunflower oils as the fat ingredients of margarine. Whale oil has been widely used in Europe but was never common in the United States.

Margarine was long subjected to severe restrictive legislation, particularly in the United States, because of the opposition of the dairy industry. But during the 1930s, margarine manufacturers learned to make margarine from domestic oils rather than the imported oils formerly used, thereby enlisting the support of U.S. cottonseed and soybean farmers. Repeal of federal and most state restrictions gradually followed, leading to the acceptance of margarine in the United States to an extent comparable with that in most European countries.